EXPLAINED: Gild | Rare Historical Photos

Do Wall Street Analysts Like Gilead Sciences Stock?

Gilead Sciences has outperformed the broader market over the past year, and analysts remain highly bullish about the stock’s prospects.

Barchart · Jul 30

Gilead Sciences' Quarterly Earnings Preview: What You Need to Know

Gilead Sciences will release its second-quarter earnings soon, and analysts anticipate a triple-digit profit dip.

Barchart · Jul 21

How Is Gilead Sciences's Stock Performance Compared to Other Healthcare Stocks

Gilead Sciences has outperformed other healthcare stocks, and analysts remain highly optimistic about the stock’s outlook

Barchart · Jun 2

2 Mega-Cap Nasdaq Stocks with Unusual Options Activity: What to Watch

By taking advantage of Barchart’s scanning tools and doing a small bit of legwork, investors can gain powerful insights.

Barchart · Mar 16

3 Top-Rated Stocks to Buy to Hedge Against Stagflation as Middle East Conflict Drags On

Amid widespread uncertainties, these three names can shield your portfolio.

Barchart · Mar 11

3 Blue-Chip Stocks Built for a Rotating Market

Investors are rotating out of overvalued mega-cap tech as the broader economy heats up; these three blue-chip stocks are attracting attention

MarketBeat · Mar 8

These 3 Cash Flow Machines Provide Stability in Uncertain Markets

Three companies with a combination of excellent name recognition within their industries and strong free cash flow potential provide a stable investment option.

MarketBeat · Mar 6

Gilead Sciences Stock: Is GILD Outperforming the Healthcare Sector?

As Gilead Sciences has outperformed its sector peers recently, analysts remain highly optimistic about the stock’s prospects.

Barchart · Feb 27

Stock Index Futures Muted With U.S. Retail Sales Data in Focus

March S&P 500 E-Mini futures (ESH26) are up +0.03%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.04% this morning, taking a breather after a recent rally as investors await a slew of U.S. economic data, with particular attention on the retail sales report, remarks from Federal Reserve officials,…

Barchart · Feb 10

This Overlooked Biotech Giant Could Surprise Investors This Quarter

Investors may be underestimating the long-term potential of Gilead’s evolving portfolio.

Barchart · Feb 5